NW
CVS icon

NewEdge Wealth’s CVS Health CVS Stock Holding History

NewEdge Wealth’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.17M Buy
20,936
+6,333
+43% +$565K 0.02% 444
2026
Q1 		$1.05M Sell
14,603
-10,496
-42% -$809K 0.01% 614
2025
Q4 		$1.99M Buy
25,099
+8,200
+49% +$646K 0.02% 448
2025
Q3 		$1.33M Sell
16,899
-18,855
-53% -$1.29M 0.02% 496
2025
Q2 		$2.27M Buy
35,754
+20,983
+142% +$1.38M 0.04% 354
2025
Q1 		$1M Buy
14,771
+376
+3% +$22.5K 0.02% 485
2024
Q4 		$646K Buy
14,395
+908
+7% +$50.9K 0.01% 581
2024
Q3 		$848K Buy
13,487
+2,644
+24% +$154K 0.02% 506
2024
Q2 		$640K Sell
10,843
-4,559
-30% -$285K 0.01% 491
2024
Q1 		$849K Sell
15,402
-523
-3% -$40K 0.02% 453
2023
Q4 		$1.26M Sell
15,925
-2,061
-11% -$147K 0.03% 366
2023
Q3 		$1.26M Sell
17,986
-2,441
-12% -$173K 0.04% 322
2023
Q2 		$1.41M Buy
20,427
+1,819
+10% +$129K 0.05% 310
2023
Q1 		$1.38M Sell
18,608
-152
-0.8% -$12.7K 0.05% 275
2022
Q4 		$1.75M Buy
18,760
+2,429
+15% +$234K 0.08% 229
2022
Q3 		$1.56M Buy
16,331
+7,158
+78% +$709K 0.07% 224
2022
Q2 		$850K Buy
9,173
+5,467
+148% +$534K 0.04% 305
2022
Q1 		$375K Buy
3,706
+640
+21% +$67.2K 0.02% 336
2021
Q4 		$316K Buy
+3,066
New +$283K 0.01% 336

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

NewEdge Wealth's CVS Position: Q2 2026 in Review

NewEdge Wealth increased its CVS Health (CVS) stake by 43% in Q2 2026, buying an estimated $565K and bringing the position to 20,936 shares worth $2.17M. The position accounts for 0.02% of the portfolio, ranked #444.

NewEdge Wealth first reported a position in CVS in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.27M in Q2 2025. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • NewEdge Wealth held 20,936 shares of CVS Health worth $2.17M as of Q2 2026.
  • NewEdge Wealth bought 6,333 CVS Health shares in Q2 2026, an estimated $565K.
  • CVS Health made up 0.02% of NewEdge Wealth's portfolio in Q2 2026, its #444 holding.
  • NewEdge Wealth first reported a position in CVS Health in Q4 2021 and has held it in 19 quarters since.
  • NewEdge Wealth's CVS Health position peaked at $2.27M in Q2 2025.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on NewEdge Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.